Two‐dimensional NMR spectroscopy of urinary glycosaminoglycans from patients with different mucopolysaccharidoses
Authors:
- 1 June 2003
- journal article
- research article
- Published by Wiley in NMR in Biomedicine
- Vol. 16 (4) , 224-236
Abstract
Patients with different types of mucopolysaccharidoses (MPS) lack specific lysosomal enzymes, which leads to tissue accumulation and urinary excretion of glycosaminoglycans (GAGs). Since little is known about the molecular composition of the excreted GAG fragments, we used two‐dimensional [1H,13C]‐correlation nuclear magnetic resonance (NMR) spectroscopy for a detailed analysis of the urinary GAGs of patients with MPS types I, II, IIIA, IVA and VI. The method revealed that the molecular structures of the excreted GAGs, i.e. heparan sulfate (HS), dermatan sulfate (DS), chondroitin sulfate (CS), and keratan sulfate (KS) are clearly distinct for the different MPS types. The chain terminal residues that are the normal substrates for the defective enzymes constitute characteristic sets of signals for each MPS type. The GAG chains show variations in carbohydrate composition and sulfation patterns that can be related to the different MPS types and clinical features. For example, two patients with MPS IIIA (M. Sanfilippo) with signs of CNS degeneration but only mild somatic features excrete a highly sulfated variant of HS, resembling HS in porcine brain, whereas a patient with MPS I (M. Scheie) and two patients with MPS II (M. Hunter), who present primarily with coarse facial features, joint contractures and skeletal deformities excrete a different type of HS with lower sulfation. In another case study, a patient with MPS IVA (M. Morquio), who presented mainly with skeletal dysplasia, excreted not only excessive amounts of KS but also a highly sulfated CS variant, resembling CS in articular cartilage. The high‐resolution NMR analysis of urinary GAGs presented here for the first time provides a solid basis for future studies with a larger number of patients to further explore pathogenesis and course of the MPS diseases. Copyright © 2003 John Wiley & Sons, Ltd.Keywords
This publication has 51 references indexed in Scilit:
- Variable clinical presentation in lysosomal storage disordersJournal of Inherited Metabolic Disease, 2001
- Recent advances in the study of the biosynthesis and functions of sulfated glycosaminoglycansCurrent Opinion in Structural Biology, 2000
- Glycosaminoglycan Accumulation and Excretion in the Mucopolysaccharidoses: Characterization and Basis of a Diagnostic Test for MPSMolecular Genetics and Metabolism, 1998
- Urine Analysis in the Diagnosis of Mucopolysaccharide DisordersAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1998
- Improved Sensitivity of HSQC Spectra of Exchanging Protons at Short Interscan Delays Using a New Fast HSQC (FHSQC) Detection Scheme That Avoids Water SaturationJournal of Magnetic Resonance, Series B, 1995
- 1H-NMR Profile of Glycosaminoglycans in Human UrineAnalytical Sciences, 1994
- A Simple Experimental Scheme Using Pulsed Field Gradients for Coherence-Pathway Rejection and Solvent Suppression in Phase-Sensitive Heteronuclear Correlation SpectraJournal of Magnetic Resonance, Series B, 1993
- Methods for analysis of urinary glycosaminoglycansJournal of Chromatography B: Biomedical Sciences and Applications, 1988
- Extracellular mammalian polysaccharides: glycosaminoglycans and proteoglycansJournal of Chromatography B: Biomedical Sciences and Applications, 1987
- The Biochemistry of Glycoproteins and Proteoglycans1980